Human medicines European public assessment report (EPAR): Deltyba, delamanid, Date of authorisation: 27/04/2014, Date of refusal: 25/07/2013, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 18 March 2026 - 15:53

Human medicines European public assessment report (EPAR): Deltyba, delamanid, Date of authorisation: 27/04/2014, Date of refusal: 25/07/2013, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Strensiq, asfotase alfa, Date of authorisation: 28/08/2015, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 18 March 2026 - 15:40

Human medicines European public assessment report (EPAR): Strensiq, asfotase alfa, Date of authorisation: 28/08/2015, Revision: 18, Status: Authorised

Opinion on medicine for use outside EU: Mosquirix, RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)], Malaria, 23/07/2015 Positive opinion

Submitted by Anonymous (not verified) on 18 March 2026 - 11:24

Opinion on medicine for use outside EU: Mosquirix, RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)], Malaria, 23/07/2015 Positive opinion

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness